Health Idea Now
Wednesday, 28 February 2018
Mylan teams up with Revance on biosimilar for Botox
NEW YORK (Reuters) - Mylan NV on Wednesday struck a licensing agreement to help bring Revance Therapeutics Inc's biosimilar of Allergan Plc's blockbuster Botox wrinkle treatment to the market.
from Reuters: Health News http://ift.tt/2CObeza
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment